Efficiently editing the Vaccinia virus genome using the CRISPR Cas9 system

  • Yuan M
  • Zhang W
  • Wang J
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


Vaccinia virus (VACV) continues to be used in immunotherapy for prevention of infectious diseases and treatment of cancer since its use for the eradication of smallpox. However, the current method for editing the VACV genome is not efficient. Here we demonstrate that the CRISPR-Cas9 system can be used to edit the VACV genome rapidly and efficiently. Additionally, a set of 8,964 computationally designed unique gRNAs targeting all VACV genes will be valuable for the study of VACV gene functions.

Author-supplied keywords

  • pathogens
  • staffpaper

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Ming Yuan

  • Wensheng Zhang

  • Jun Wang

  • Chadwan A Yaghchi

  • Jahangir Ahmed

  • Louisa Chard

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free